AG
SLDB icon

Advisor Group’s Solid Biosciences SLDB Stock Holding History

Advisor Group’s Portfolio SLDB Stock Details SLDB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2K Hold
24
– – ﹤0.01% 5017
2019
Q3 		$4K Hold
24
– – ﹤0.01% 4776
2019
Q2 		$2K Hold
24
– – ﹤0.01% 5003
2019
Q1 		$3K Buy
+24
New +$6.01K ﹤0.01% 4866

Other funds holding SLDB

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Advisor Group's SLDB Position: Q4 2019 in Review

Advisor Group held its Solid Biosciences (SLDB) position steady in Q4 2019 at 24 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #5017.

Advisor Group first reported a position in SLDB in Q1 2019 and has held it in 4 quarters since. The position peaked at $4K in Q3 2019. 69 funds tracked by Wall St. Rank hold SLDB as of Q4 2019.

  • Advisor Group held 24 shares of Solid Biosciences worth $2K as of Q4 2019.
  • Advisor Group left its Solid Biosciences share count unchanged in Q4 2019.
  • Solid Biosciences made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #5017 holding.
  • Advisor Group first reported a position in Solid Biosciences in Q1 2019 and has held it in 4 quarters since.
  • Advisor Group's Solid Biosciences position peaked at $4K in Q3 2019.
  • 69 funds tracked by Wall St. Rank held Solid Biosciences as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.